4//SEC Filing
Douglas Earl Martin 4
Accession 0001737287-25-000020
CIK 0001737287other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:16 PM ET
Size
5.0 KB
Accession
0001737287-25-000020
Insider Transaction Report
Form 4
Douglas Earl Martin
SVP, General Counsel
Transactions
- Sale
Common Stock
2025-02-03$1.71/sh−6,404$10,951→ 587,848 total
Footnotes (1)
- [F1]Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001362155
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 4:16 PM ET
- Size
- 5.0 KB